Company type
One of the best-known health-care brands in the world and offers one of the most comprehensive product portfolios in the ophthalmic industry.Funding rounds
Acquisition USD 8,700,000,000
USD 8,700,000,000 ( ) at USD 8,700,000,000 pre-money valuation
Investor | Profile | Country | Notes | |
---|---|---|---|---|
![]() |
Valeant Pharmaceuticals International | USD 8,700,000,000 (USD 8,700,000,000) Initial investment. Led the round. |
Investment activity status
Active investor
Selected investments
Displaying 1 - 1 of 1Company | Profile | Country | Funding | ||
---|---|---|---|---|---|
![]() |
eyeonics Inc | N/A |